The 2024 EuropaBio annual report highlights work, partnerships and accomplishments over the last year, with updates from the Healthcare, Industrial Biotechnology and National Associations Councils, plus SME and Biomanufacturing Platforms.

In the last period, biotechnology and biomanufacturing, along with EuropaBio, have achieved unprecedented political attention across sectors, being recognised as integral to Europe’s industrial, competitive and sustainable future.

Biotechnology has been recognised as a critical technology for economic security, included within the regulation ‘Strategic Technologies for Europe Platform (STEP)’, the Net Zero Industry Act (NZIA) and Competitiveness Council conclusions as recently as May 2024.

2024 also saw the publication of the EC Communication “Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU”, recognising the need for coherence and ambition in the delivery of biotechnology if it is to achieve the global ambition referenced by European leaders.

The report also looks ahead for EuropaBio and biotechnology, for the coming European Commission mandate and focus towards a potential Biotech Act.

To find out more about Europabio membership and how you can bring your voice to the discussion, read more HERE and contact us.